Lantern Pharma Inc. (LTRN) › Operating Cash FlowLantern Pharma Inc. (LTRN) — Operating Cash FlowAnnual figures by period end, from SEC filings.2019-12-31: -$2.13M2020-12-31: -$5.65M2021-12-31: -$10.59M2022-12-31: -$12.77M2023-12-31: -$14.35M2024-12-31: -$17.81M2025-12-31: -$15.68M-$15.68M2019-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$15.68M—2026-03-30From 2025-01-012024-12-31-$17.81M—2026-03-30From 2024-01-012023-12-31-$14.35M—2025-03-27From 2023-01-012022-12-31-$12.77M—2024-03-18From 2022-01-012021-12-31-$10.59M—2023-03-20From 2021-01-012020-12-31-$5.65M—2022-03-10From 2020-01-012019-12-31-$2.13M—2021-03-10From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)